* 2008/9 – excludes Trust-to-Trust income and education funding,
so does not represent total Trust income.
A growing market
Heart and lung diseases are the world’s biggest killers. Overall,
the markets for their treatment are therefore strong and growing, as a
result of both increased need and national policy initiatives to meet
that need.
Our international role
The Trust does not operate in a single, local health
economy, but treats patients from across the UK (and more than 50
countries overseas). We are leaders for specialist heart and lung care
in the NHS. Sustained and sustainable growth in patient care, partly as
a result of patient choice, has enabled us to absorb the impact of
changes in the research and development market, which nonetheless
remains an important source of both income and innovation for service
development.
A strong reputation
Our strong reputation enables us to maintain and
grow our market position, both by developing new interventions and by
securing referral patterns through established networks of referring
hospitals.
